Evidence map›Paper›PMID 30846427›Full record

ArticleBlood advances2019

Inactivation of platelet-derived TGF-β1 attenuates aortic stenosis progression in a robust murine model.

Rohan Varshney, Brennah Murphy, Sean Woolington, Shahrouz Ghafoory, Sixia Chen, Tyler Robison, Jasimuddin Ahamed

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Novel Circulating Biomarkers in Aortic Valve Stenosis.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. A novel mouse model of calcific aortic valve stenosis.Animal models and experimental medicine · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rohan VarshneyCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; and.
Brennah MurphyCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; and.
Sean WoolingtonCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; and.
Shahrouz GhafooryCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; and.
Sixia ChenDepartment of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
Tyler RobisonCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; and.
Jasimuddin AhamedCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; and.
Oklahoma Medical Research Foundation · USUniversity of Oklahoma Health Sciences Center · US

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI TIMOTHY M VANWAGONER · 2013 to 2026
$68.2M
Pilot ProjectP30GM114731 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI MCEVER, RODGER PAUL · 2016 to 2020
$6.5M
The Role of TGF-beta Activation and Signaling in Aortic Stenosis ProgressionR01HL148123 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Jasimuddin Ahamed · 2020 to 2026
$2.9M
Safer Approaches to CRC ChemopreventionR01CA213987 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI RAO, CHINTHALAPALLY V. · 2017 to 2021
$2.4M
The Mechanism of Shear-Induced Release and Activation of TGF-beta1R01HL123605 · NHLBI · ROCKEFELLER UNIVERSITY · PI AHAMED, JASIMUDDIN · 2015 to 2018
$1.7M
NCI NIH HHS R01 CA213987NHLBI NIH HHS R01 HL123605NHLBI NIH HHS R01 HL148123NIGMS NIH HHS P30 GM114731NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

Aortic stenosis (AS) is a degenerative heart condition characterized by fibrosis and narrowing of aortic valves (AV), resulting in high wall shear stress (WSS) across valves. AS is associated with high plasma levels of transforming growth factor-β1 (TGF-β1), which can be activated by WSS to induce organ fibrosis, but the cellular source of TGF-β1 is not clear. Here, we show that platelet-derived TGF-β1 plays an important role in AS progression. We first established an aggressive and robust murine model of AS, using the existing

Indexed as

AnimalsAortic Valve StenosisBlood PlateletsCollagenDiet, High-FatDisease Models, AnimalDisease ProgressionEndothelial CellsMiceMyofibroblastsTransforming Growth Factor beta1UltrasonographyCollagenTGFB1 protein, humanTransforming Growth Factor beta1

Identifiers

PMID30846427
PMCPMC6418501
OpenAlexW2920811033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.